Clinical trial

TC-5214 as Augmentation Therapy in Patients With Refractory Hypertension

NCT00899977

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2009-05-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2009-05-01Date precision: month

Registry last updated2013-09-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Refractory Hypertensionunresolved

Interventions

PlaceboDRUG

TC-5214DRUG

Sponsors & collaborators

Targacept Inc.lead sponsor

Mapped research locations

Winston-SalemNorth Carolina, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00899977 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.